Podcasts about radboud university medical centre

In this episode, host Helen Angus, CEO of AMS Healthcare, speaks with Will Falk and Dr. Zayna Khayat.  Will Falk has spent over 25 years as an international strategist, advising top academic centres, governments, and innovative companies in healthcare. He is currently the Board Chair of AMS Healthcare's Board of Directors, an Adjunct Professor at the Rotman School of Management at the University of Toronto, and a Senior Fellow at the C.D. Howe Institute. Will is interested in the impacts of technological change on health systems and their governance and payment mechanisms. He works with several innovative enterprises in digital health and software development, including as an Innovation Fellow at Women's College Hospital Institute for Health System Solutions and Virtual Care. He has also served as a Board Director or Advisor for more than a dozen enterprises, including local and national charities, start-ups, health systems, and publicly listed companies. Will's strong understanding of digital health, along with his commitment to improving healthcare through policy and innovation, makes him an important part of AMS as we focus on a system shaped by advancing technology while remaining rooted in compassion. Zayna Khayat, PhD, is the Chief Program Officer at AMS Healthcare, where she leads the strategic design and delivery of the organization's flagship programs in Artificial Intelligence & Compassion.  She is adjunct faculty in the Health Sector Strategy stream at the Rotman School of Management, University of Toronto. Zayna previously held senior roles as Future Strategist at SE Health, Lead of Health System Innovation at MaRS Discovery District, and was seconded to the REshape Innovation Centre at Radboud University Medical Centre in the Netherlands. Earlier in her career, she was a Principal in the healthcare practice of The Boston Consulting Group.  Zayna earned her PhD in diabetes research from the University of Toronto. A recognized voice on health system transformation, she advises health technology companies across Canada and internationally. https://amshealthcare.ca/

This episode features Dr Nicola White (Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London, London, UK), Dr Christina Gerlach (University Medical Center Hamburg-Eppendorf, Hamburg, Germany), Dr Bert Leysen (Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK) and Prof Yvonne Engels (Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands). The Surprise Question (‘Would I be surprised if this patient died within 12 months?') is a screening tool which is used to identify patients with palliative care needs. The Surprise Question alone is not a very accurate way to prognosticate. It is not known whether prognostication with the Surprise Question is difficult because clinicians are intrinsically poor prognosticators, because the Surprise Question is interpreted in different ways by different clinicians, of because clinicians themselves are inconsistent in their level of surprise. Our study suggests that the threshold probability, before a death causes surprise, varies across six European countries. Many GPs (including those with specialist palliative care training) are inconsistent about the probability of death that elicits surprise. Further research is needed to understand how the Surprise Question is used in practice, and whether consistency and accuracy could be improved by modifying the Surprise Question, or by training GPs in its use.

After 22 years of searching, researchers at the Radboud University Medical Centre in the Netherlands have successfully identified the genetic cause behind a certain type of inherited adult hearing loss - a defect in the so-called RIPOR2 gene. Eva Higginbotham spoke to geneticist Hannie Kremer and ear nose and throat surgeon Ronald Pennings about how they did it. Like this podcast? Please help us by supporting the Naked Scientists

After 22 years of searching, researchers at the Radboud University Medical Centre in the Netherlands have successfully identified the genetic cause behind a certain type of inherited adult hearing loss - a defect in the so-called RIPOR2 gene. Eva Higginbotham spoke to geneticist Hannie Kremer and ear nose and throat surgeon Ronald Pennings about how they did it. Like this podcast? Please help us by supporting the Naked Scientists

In this conversation we talk about the science of language. How does language work? What is language and how does it impact us every day? We discuss how language makes us uniquely human and where do the borders lie if there are any. We also talk about the overlaps of language and memory. Our guest is Dr. Vitoria Piai. Vitória is a senior researcher at the Donders Centre for Cognition and the Radboud University Medical Centre. Her research focuses on language function in healthy and neurological populations, such as stroke, brain tumor, epilepsy, and neurodegenerative disorders such as dementia or Parkinson's. She pays special attention to the intersection of language and other functions, such as executive control, (semantic) memory, and motor control in the case of speaking. 

Dr. Zayna Khayat, Future Strategist with SE Health, joins Ben & Ann Somers on a wide-ranging conversation about the future of health and how to drive innovation. Before recently joining SE Health (formerly Saint Elizabeth Health Care), Zayna served as “Innovation Sherpa in Chief” at the REshape Health Innovation Centre at Radboud University Medical Centre in Nijmegen, Netherlands. Yes, she is truly a Sherpa, so of course we are thrilled to have her as our first international guest! Zayna has been on faculty of Singularity University's Exponential Medicine stream since 2016. She is also an adjunct faculty with the University of Toronto's Rotman School of Management in the Health Sector Strategy stream.@ZaynaKhayat @SEFutures@TheBenReport @annsomerswh #InnovationEngine - A Sherpa's Guide to Innovation is a proud member of the Health Podcast Network @HealthPodNet -Support the show (https://healthpodcastnetwork.com/)

Some women who have ovarian stimulation for assisted reproduction will experience an adverse effect called ovarian hyperstimulation syndrome, or OHSS. There are several Cochrane Reviews of strategies to prevent this and a new overview in January 2017 brings together the findings from these systematic reviews. The lead author, Selma Mourad from Radboud University Medical Centre in Nijmegen in the Netherlands summarises this large evidence base in this podcast.

Some women who have ovarian stimulation for assisted reproduction will experience an adverse effect called ovarian hyperstimulation syndrome, or OHSS. There are several Cochrane Reviews of strategies to prevent this and a new overview in January 2017 brings together the findings from these systematic reviews. The lead author, Selma Mourad from Radboud University Medical Centre in Nijmegen in the Netherlands summarises this large evidence base in this podcast.

Martin Dresler, PhD, is an Assistant Professor for Cognitive Neuroscience at the Radboud University Medical Centre and Donders Institute in Nijmegen, the Netherlands. He received Master’s degrees in Psychology and Philosophy from Ruhr University Bochum and a PhD from Philipps University Marburg, and performed postdoctoral research on sleep, dreams, and memory function at the Max Planck Institute of Psychiatry, Oxford University and Stanford University.

: An-Dinh Nguyen interviews Heidi Carmen Howard of Radboud University Medical Centre and INSERM on 16 October 2013. Dr. Howard will be speaking during the Genome Informatics conference at the Clinical Genomics & Informatics Europe Conference & Expo on 4-6 December, in Lisbon, Portugal. Topics include: • The Translation of Genetic Data into the Clinic • The Necessity of Ethical, Social and Legal Considerations in Genomics • Genetics for Consumers, Patients and Public Health